U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07658053) titled 'Effects of a Pacifier on Obstructive Sleep Apnea and Its Repercussions in Infants With Down Syndrome' on May 20.
Brief Summary: Obstructive Sleep Apnea (OSA) is characterised by repetitive collapse of the upper airway during sleep, inducing breathing disturbances that can result in oxygen desaturation and frequent arousals. In children, OSA can have long-term consequences on the development and on the cardiovascular system.
Down Syndrome (DS) is a genetic disorder associated with intellectual disability and many comorbidities. The prevalence of OSA is particularly high in patients with DS, from infancy. In a recent study, OSA was d...